{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:04:59Z","timestamp":1784822699958,"version":"3.55.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#32470636"],"award-info":[{"award-number":["#32470636"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Scholar Programme of Shandong Province","award":["#tsqn202211377"],"award-info":[{"award-number":["#tsqn202211377"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["#ZR2024MH031"],"award-info":[{"award-number":["#ZR2024MH031"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Province Key Research and Development Program Major Science and Technology Innovation","award":["#2021ZDSYS06"],"award-info":[{"award-number":["#2021ZDSYS06"]}]},{"name":"Shandong Province Key Research and Development Program Major Science and Technology Innovation","award":["#2021CXGC011103"],"award-info":[{"award-number":["#2021CXGC011103"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Obesity affects 53% of gout patients, while its effect on urate-lowering therapy (ULT) is unclear. This study aimed to compare the response to febuxostat among different BMI catalogs of male gout patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective study recruited 633 men with gout, classified by BMI into normal-weight, overweight and obese groups. Baseline age, disease duration and serum urate (SU) levels were matched simultaneously. All participants received febuxostat for 12\u2009weeks, increasing the dosage from 20 to 40\u2009mg daily. We compared the efficacy of ULT and the incidence of gout flares in three groups. Cox regression analysis was used to identify risk factors for achieving target SU levels before and after matching. Restricted cubic spline (RCS) curves were used to illustrate the relationship between BMI and hazard ratio (HR) for SU achievement.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The proportion of participants achieving SU &amp;lt; 6.0\u2009mg\/dl in the obese group was 38.9%, significantly lower than the overweight (54.2%) and normal-weight groups (63.8%) (P &amp;lt; 0.05), with no significant difference between the overweight and normal-weight groups at week 12. High BMI (HR\u2009=\u20090.92, 95% CI 0.89\u20130.96, P &amp;lt; 0.001) independently prevented achieving the SU target, with a similar effect after matching. Obese and overweight individuals had a higher cumulative incidence of gout flares compared with the normal-weight group (P &amp;lt; 0.05). The linear relationship between BMI and HR for achieving the SU target was suggested by RCS (nonlinear P &amp;gt; 0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Obesity significantly reduces the efficacy of febuxostat-based ULT in male gout patients rather than being overweight.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>China Clinical Trial Registry, #ChiCTR2300078804.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf076","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T16:34:36Z","timestamp":1739205276000},"page":"3500-3508","source":"Crossref","is-referenced-by-count":5,"title":["Obesity reduces the urate-lowering efficacy among patients with primary gout: a prospective cohort study"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9312-8464","authenticated-orcid":false,"given":"Zan","family":"Cheng","sequence":"first","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Yantai Yeda Hospital , Yantai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Qi","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2002-7353","authenticated-orcid":false,"given":"Yushuang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Qingdao Zhanshan Sanatorium , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Ji","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2446-0725","authenticated-orcid":false,"given":"Bingzi","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-3731","authenticated-orcid":false,"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2886-8285","authenticated-orcid":false,"given":"Jie","family":"Lu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"2025052703541916700_keaf076-B1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","article-title":"Gout","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Nat Rev Dis Primer"},{"key":"2025052703541916700_keaf076-B2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","article-title":"Gout epidemiology and comorbidities","volume":"50","author":"Singh","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025052703541916700_keaf076-B3","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/art.41404","article-title":"Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990\u20132017: a systematic analysis of the global burden of disease study 2017","volume":"72","author":"Safiri","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025052703541916700_keaf076-B4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2025052703541916700_keaf076-B5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025052703541916700_keaf076-B6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3899\/jrheum.170806","article-title":"The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years","volume":"45","author":"Elfishawi","year":"2018","journal-title":"J Rheumatol"},{"key":"2025052703541916700_keaf076-B7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13075-018-1612-1","article-title":"Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies","volume":"20","author":"Evans","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025052703541916700_keaf076-B8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13098-024-01268-1","article-title":"Relationship between gout, hyperuricemia, and obesity\u2014does central obesity play a significant role?\u2014a study based on the NHANES database","volume":"16","author":"Mao","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"2025052703541916700_keaf076-B9","doi-asserted-by":"crossref","first-page":"94893","DOI":"10.18632\/oncotarget.22046","article-title":"Physical exercises and weight loss in obese patients help to improve uric acid","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"2025052703541916700_keaf076-B10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13075-021-02461-7","article-title":"Incident gout and weight change patterns: a retrospective cohort study of US adults","volume":"23","author":"Bai","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025052703541916700_keaf076-B11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025052703541916700_keaf076-B12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2025052703541916700_keaf076-B13","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2147\/JIR.S458250","article-title":"Predictors of inadequate serum urate response to low-dose febuxostat in male patients with gout","volume":"17","author":"Sun","year":"2024","journal-title":"J Inflamm Res"},{"key":"2025052703541916700_keaf076-B14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1748-1716.2011.02290.x","article-title":"Obesity, blood vessels and metabolic syndrome","volume":"203","author":"Tesauro","year":"2011","journal-title":"Acta Physiol Oxf Engl"},{"key":"2025052703541916700_keaf076-B15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00296-009-1304-x","article-title":"Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis","volume":"31","author":"Yoo","year":"2011","journal-title":"Rheumatol Int"},{"key":"2025052703541916700_keaf076-B16","doi-asserted-by":"crossref","first-page":"27138","DOI":"10.1074\/jbc.M113.485094","article-title":"Uric acid secretion from adipose tissue and its increase in obesity","volume":"288","author":"Tsushima","year":"2013","journal-title":"J Biol Chem"},{"key":"2025052703541916700_keaf076-B17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/BOR.0b013e3282f4b1ed","article-title":"Hyperuricemia, gout and the metabolic syndrome","volume":"20","author":"Puig","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"2025052703541916700_keaf076-B18","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/art.41779","article-title":"Assessing the causal relationships between insulin resistance and hyperuricemia and gout using bidirectional mendelian randomization","volume":"73","author":"McCormick","year":"2021","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"2025052703541916700_keaf076-B19","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025052703541916700_keaf076-B20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet Lond. Engl"},{"key":"2025052703541916700_keaf076-B21","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2014study on optimal cut-off points of body mass index and waist circumference in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci BES"},{"key":"2025052703541916700_keaf076-B22","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/art.42266","article-title":"Superiority of low-dose benzbromarone to low-dose febuxostat in a prospective, randomized comparative effectiveness trial in gout patients with renal uric acid underexcretion","volume":"74","author":"Yan","year":"2022","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"2025052703541916700_keaf076-B23","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/art.33483","article-title":"Developing a provisional definition of flare in patients with established gout","volume":"64","author":"Gaffo","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025052703541916700_keaf076-B24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40885-020-00141-3","article-title":"Highlights of the 2018 Chinese hypertension guidelines","volume":"26","author":"Liu","year":"2020","journal-title":"Clin Hypertens"},{"key":"2025052703541916700_keaf076-B25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/cd17-0119","article-title":"Standards of medical care in diabetes-2018 abridged for primary care providers","volume":"36","author":"American Diabetes Association","year":"2018","journal-title":"Clin Diabetes Publ Am Diabetes Assoc"},{"key":"2025052703541916700_keaf076-B26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/keaa366","article-title":"Ultrasound for the diagnosis of gout-the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group","volume":"60","author":"Christiansen","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"2025052703541916700_keaf076-B27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.40381","article-title":"Brief report: validation of a definition of flare in patients with established gout","volume":"70","author":"Gaffo","year":"2018","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"2025052703541916700_keaf076-B28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2025052703541916700_keaf076-B29","doi-asserted-by":"crossref","first-page":"16494","DOI":"10.1038\/srep16494","article-title":"ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"2025052703541916700_keaf076-B30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mend\u00eda","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"2025052703541916700_keaf076-B31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13075-023-03228-y","article-title":"Response to febuxostat according to clinical subtypes of hyperuricemia: a prospective cohort study in primary gout","volume":"25","author":"Qi","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2025052703541916700_keaf076-B32","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1007\/s10067-019-04737-5","article-title":"Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial","volume":"38","author":"Mu","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025052703541916700_keaf076-B33","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/bcp.16005","article-title":"The development and evaluation of dose-prediction tools for allopurinol therapy (Easy-Allo tools)","volume":"90","author":"Wright","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"2025052703541916700_keaf076-B34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/rheumatology\/keab283","article-title":"Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study","volume":"61","author":"Bajpai","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"2025052703541916700_keaf076-B35","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.2174\/0929867323666160725091915","article-title":"Xanthine oxidoreductase in drug metabolism: beyond a role as a detoxifying enzyme","volume":"23","author":"Battelli","year":"2016","journal-title":"Curr Med. Chem"},{"key":"2025052703541916700_keaf076-B36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.metabol.2017.01.031","article-title":"Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans","volume":"70","author":"Washio","year":"2017","journal-title":"Metabolism"},{"key":"2025052703541916700_keaf076-B37","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/oby.22202","article-title":"Hypoxanthine secretion from human adipose tissue and its increase in hypoxia","volume":"26","author":"Nagao","year":"2018","journal-title":"Obes Silver Spring Md"},{"key":"2025052703541916700_keaf076-B38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cmet.2007.01.005","article-title":"Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity","volume":"5","author":"Cheung","year":"2007","journal-title":"Cell Metab"},{"key":"2025052703541916700_keaf076-B39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10753-021-01559-z","article-title":"Role of inflammatory cytokines, growth factors and adipokines in adipogenesis and insulin resistance","volume":"45","author":"Al-Mansoori","year":"2022","journal-title":"Inflammation"},{"key":"2025052703541916700_keaf076-B40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med"},{"key":"2025052703541916700_keaf076-B41","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.hjh.0000239300.48130.07","article-title":"Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study","volume":"24","author":"Strazzullo","year":"2006","journal-title":"J. Hypertens"},{"key":"2025052703541916700_keaf076-B42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000495665","article-title":"Beta cell functional adaptation and dysfunction in insulin resistance and the role of chronic kidney disease","volume":"143","author":"Sto\u017eer","year":"2019","journal-title":"Nephron"},{"key":"2025052703541916700_keaf076-B43","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/acr.22855","article-title":"Association of serum uric acid and disease duration with frequent gout attacks: a case-control study","volume":"68","author":"Abhishek","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2025052703541916700_keaf076-B44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/rheumatology\/keab283","article-title":"Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study","volume":"61","author":"Bajpai","year":"2021","journal-title":"Rheumatology"},{"key":"2025052703541916700_keaf076-B45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3899\/jrheum.180761","article-title":"Hepatic safety of febuxostat compared with allopurinol in gout patients with fatty liver disease","volume":"46","author":"Lee","year":"2019","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf076\/61820072\/keaf076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/3500\/61820072\/keaf076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/3500\/61820072\/keaf076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T07:54:37Z","timestamp":1748332477000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/6\/3500\/8006492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,2,10]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf076","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,2,10]]}}}